Jan Fiedler

9.5k total citations · 1 hit paper
66 papers, 3.4k citations indexed

About

Jan Fiedler is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jan Fiedler has authored 66 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 38 papers in Cancer Research and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jan Fiedler's work include MicroRNA in disease regulation (32 papers), Circular RNAs in diseases (19 papers) and Cancer-related molecular mechanisms research (17 papers). Jan Fiedler is often cited by papers focused on MicroRNA in disease regulation (32 papers), Circular RNAs in diseases (19 papers) and Cancer-related molecular mechanisms research (17 papers). Jan Fiedler collaborates with scholars based in Germany, United Kingdom and United States. Jan Fiedler's co-authors include Thomas Thum, Johann Bauersachs, Paolo Galuppo, Susanne Kneitz, Georg Ertl, Christine L. Mummery, Shashi Kumar Gupta, Christian Wolf, Pieter A. Doevendans and Axel Haverich and has published in prestigious journals such as Circulation, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Fiedler

62 papers receiving 3.4k citations

Hit Papers

MicroRNAs in the Human Heart 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Fiedler Germany 29 2.3k 1.9k 538 431 215 66 3.4k
Simona Greco Italy 33 2.6k 1.1× 2.0k 1.1× 455 0.8× 254 0.6× 278 1.3× 70 3.9k
Wai Ho Tang China 18 2.1k 0.9× 1.1k 0.6× 246 0.5× 247 0.6× 326 1.5× 28 3.0k
Chengxing Shen China 24 1.3k 0.5× 728 0.4× 479 0.9× 451 1.0× 230 1.1× 72 2.4k
Marianna Prokopi United Kingdom 14 1.9k 0.8× 1.6k 0.8× 250 0.5× 254 0.6× 208 1.0× 20 2.6k
Bin Yu China 33 2.6k 1.1× 1.4k 0.7× 520 1.0× 570 1.3× 671 3.1× 176 4.9k
Xavier Loyer France 29 2.2k 1.0× 1.1k 0.6× 898 1.7× 528 1.2× 634 2.9× 50 3.5k
Charles Searles United States 25 1.5k 0.7× 1.0k 0.5× 465 0.9× 254 0.6× 191 0.9× 50 2.4k
Christian Bär Germany 28 1.7k 0.7× 1.1k 0.6× 461 0.9× 172 0.4× 118 0.5× 87 2.5k
Mark W.M. Schellings Netherlands 18 1.1k 0.5× 777 0.4× 1.1k 2.0× 363 0.8× 111 0.5× 24 2.3k

Countries citing papers authored by Jan Fiedler

Since Specialization
Citations

This map shows the geographic impact of Jan Fiedler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Fiedler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Fiedler more than expected).

Fields of papers citing papers by Jan Fiedler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Fiedler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Fiedler. The network helps show where Jan Fiedler may publish in the future.

Co-authorship network of co-authors of Jan Fiedler

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Fiedler. A scholar is included among the top collaborators of Jan Fiedler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Fiedler. Jan Fiedler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fuchs, Maximilian, Annette Just, Angelika Pfanne, et al.. (2024). Ex vivo modelling of cardiac injury identifies ferroptosis-related pathways as a potential therapeutic avenue for translational medicine. Journal of Molecular and Cellular Cardiology. 196. 125–140. 5 indexed citations
2.
Xiao, Ke, Maximilian Fuchs, Annette Just, et al.. (2024). Inhibition of miR-21: cardioprotective effects in human failing myocardium ex vivo. European Heart Journal. 45(22). 2016–2018. 12 indexed citations
3.
Groß, Sonja, Annette Just, Angelika Pfanne, et al.. (2024). SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation. Scientific Reports. 14(1). 16459–16459. 10 indexed citations
4.
Jordan, Maria C., et al.. (2024). De novo establishment of an ex vivo culture for living myocardial slices applying a microphysiological system – MPSlms. SHILAP Revista de lepidopterología. 10(4). 347–350.
5.
Jordan, Maria C., Mandy Otto, Stevan D. Stojanović, et al.. (2024). The role of fibrosis in cardiomyopathies: An opportunity to develop novel biomarkers of disease activity. Matrix Biology. 128. 65–78. 7 indexed citations
6.
Fuchs, Maximilian, Stevan D. Stojanović, Chunguang Liang, et al.. (2022). Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling. Frontiers in Cardiovascular Medicine. 9. 877450–877450.
7.
Couch, Liam S., Jan Fiedler, Eef Dries, et al.. (2021). Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure. Cardiovascular Research. 118(7). 1758–1770. 38 indexed citations
8.
Sonnenschein, Kristina, Jan Fiedler, David de Gonzalo‐Calvo, et al.. (2021). Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy. Scientific Reports. 11(1). 1755–1755. 9 indexed citations
9.
Schmidt, K. E., et al.. (2021). Alternative strategies in cardiac preclinical research and new clinical trial formats. Cardiovascular Research. 118(3). 746–762. 20 indexed citations
10.
Fuchs, Maximilian, Lorenz A. Kapsner, Annette Just, et al.. (2020). Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies. International Journal of Molecular Sciences. 21(13). 4727–4727. 14 indexed citations
11.
Schimmel, Katharina, Stevan D. Stojanović, Cheng-Kai Huang, et al.. (2020). Combined high-throughput library screening and next generation RNA sequencing uncover microRNAs controlling human cardiac fibroblast biology. Journal of Molecular and Cellular Cardiology. 150. 91–100. 13 indexed citations
12.
Sonnenschein, Kristina, David de Gonzalo‐Calvo, Angelika Pfanne, et al.. (2019). Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy. Scientific Reports. 9(1). 20350–20350. 57 indexed citations
13.
Fiedler, Jan, Da‐Hee Park, Angelika Pfanne, et al.. (2019). Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease. Journal of Cardiovascular Translational Research. 12(5). 447–458. 8 indexed citations
14.
Ishikawa, Daichi, Ulf Diekmann, Jan Fiedler, et al.. (2017). miRNome Profiling of Purified Endoderm and Mesoderm Differentiated from hESCs Reveals Functions of miR-483-3p and miR-1263 for Cell-Fate Decisions. Stem Cell Reports. 9(5). 1588–1603. 21 indexed citations
15.
Lorenzen, Johan M., Tamás Kaucsár, Celina Schauerte, et al.. (2014). MicroRNA-24 Antagonism Prevents Renal Ischemia Reperfusion Injury. Journal of the American Society of Nephrology. 25(12). 2717–2729. 122 indexed citations
16.
Fiedler, Jan, Sándor Bátkai, & Thomas Thum. (2014). MicroRNA-based therapy in cardiology. Herz. 39(2). 194–200. 12 indexed citations
17.
Fiedler, Jan, Andrea Stöhr, Shashi Kumar Gupta, et al.. (2013). Functional MicroRNA Library Screening Identifies the HypoxaMiR MiR-24 as a Potent Regulator of Smooth Muscle Cell Proliferation and Vascularization. Antioxidants and Redox Signaling. 21(8). 1167–1176. 43 indexed citations
18.
Bang, Claudia, Jan Fiedler, & Thomas Thum. (2011). Cardiovascular Importance of the MicroRNA‐23/27/24 Family. Microcirculation. 19(3). 208–214. 84 indexed citations
19.
Uçar, Ahmet, Vida Vafaizadeh, Hubertus Jarry, et al.. (2010). miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. Nature Genetics. 42(12). 1101–1108. 125 indexed citations
20.
Thum, Thomas, Coleman Gross, Jan Fiedler, et al.. (2008). Prevention of cardiac hypertrophy and failure in vivo by a novel microRNA antagonist. European Journal of Heart Failure Supplements. 7. 149–149. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026